Skip to main content

HOPA Abstracts

Smart Solutions: Leveraging Artificial Intelligence in Investigational Drug Services
Abstract #LB01
Travis Smith, PharmD, MBA; Alan Yee, PharmD, MS; Camille Walters, PharmD
Read More
Evaluating the Value of Clinical Oncology Pharmacists: Time-Savings for Healthcare Providers in The US Oncology Network
Abstract #LB02
Julianne Darling, PharmD, BCOP; Hilary Conkling, PharmD, BCOP; Alexa Basilio, PharmD, BCOP; Brittney Hale, PharmD, BCOP; Dan Kendzierski, PharmD, BCOP; Andrea Roman, PharmD, BCOP, et al.
Read More
Incorporation of a Statewide Cancer Drug Repository Program Within an Integrated Specialty Pharmacy
Abstract #LB03
Melisa McKendry, RPh, MSEd; Emily Mackler, PharmD, BCOP; Kimberly Melgarejo, PharmD, MHA; Siobhan Norman
Read More
Choice of Antifungal Prophylaxis and Risk for Invasive Fungal Disease in Patients With Acute Leukemia Receiving Oral Anticancer Therapies With Significant CYP450 Drug Interactions
Abstract #LB04
Matthew Yacobucci, PharmD, BCOP; Zhenzi Hong; Colby Webster; Alexis Gregoire; Ejemen Aigbedion
Read More
Evaluation of Fam-Trastuzumab Deruxtecan Utilization Among Patients With Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Abstract #LB05
Matt Arango, PharmD, BCOP; Hiba Alzouby, PharmD, BCOP; Ning Jin, MD; Ashish Manne, MBBS; Arjun Mittra, MD; Anne Noonan, MB ChB, PhD
Read More
Role of CYP2D6 Phenotypes in Doxorubicin-Related Cardiotoxicity
Abstract #LB06
Oksana O. Karpenko, PharmD, RPh, BCPS; Jodi L. Taraba, PharmD, MS, RPh, BCOP; Ross A. Dierkhising, MS; Kristin C. Cole, MS; Corina J. Doleski, PharmD, RPh, BCOP; Karthik V. Giridhar, MD, et al.
Read More
Implementation of an Oral Oncolytic Monitoring Pilot Program: A Specialty Pharmacist–Led Approach Using the Revised Edmonton Symptom Assessment System
Abstract #LB07
Clarissa Wilkins, PharmD, BCOP; Alexandra Ritenour, PharmD, CSP
Read More
Pressurized Intraperitoneal Aerosolized Chemotherapy: Operationalizing From a Pharmacy Perspective at a Large Academic Medical Center
Abstract #LB08
Aimee Merkert, PharmD; Megan Hinton, PharmD
Read More
Biodistribution and Shedding Analysis Following RP1 Oncolytic Immunotherapy Dosing in Patients From the IGNYTE Clinical Trial: Implications for Oncology Pharmacists
Abstract #CR02
Christina Davis, PharmD, BCOP; Praveen K. Bommareddy, PhD, BPharm, MS; Alina Monteagudo, PhD; Mohammed M. Milhem, MD; Joseph J. Sacco, MD; Tawnya Lynn Bowles, MD, et al.
Read More
Assessing Student Pharmacists’ Knowledge and Perceptions of Financial Toxicity Concepts Introduced in an Oncology Pharmacotherapy Course
Abstract #CR01
Charles Wight, PharmD; Matthew DellaVecchia, PhD; Nicholas Chow, PharmD, BCOP; Monica Tadros, PharmD, BCPS, BCOP
Read More
Page 3 of 12
Results 21 - 30 of 119